Over a period of more than 40 years, Taiwan has built up a strong environment for immunization, drastically decreasing once-prevalent diseases and generating widespread trust in Taiwan’s public health system. However, while Taiwanese citizens currently enjoy almost universal access to a wide range of publicly funded vaccines, insufficiencies in that funding threatens to reduce the…

Most of AmCham Taipei’s member companies in the medical device field are sales and marketing arms of the world’s major multinational, especially American, brands. The profiles below introduce two member companies that are exceptions in that their forte is manufacturing, with Taiwan as their main base. As private companies they don’t disclose their financial information,…

Several of the candidates for the Democratic nomination for U.S. president are advocating a government-run plan to provide health-insurance coverage to all Americans, sometimes referred to “Medicare for All.” As a single-payer healthcare system, this type of plan is similar to Taiwan’s National Health Insurance (NHI). Could the Taiwan experience serve as a practical reference…

It’s imperative to devote more resources to infectious-disease control, leading to the development of new antibiotics. In 2015, the U.S. White House launched a national action plan against antimicrobial resistance (AMR), also commonly known as antibiotic resistance. In 2017, the World Health Organization (WHO) announced the 12 types of highly resistant bacteria that pose the…

If you’ve taken any medicine lately in the Asia-Pacific region, it’s highly likely that Zuellig Pharma delivered it to your healthcare provider or pharmacy. Distributing pharmaceuticals is a complex business involving cold-chain management and other massive logistical challenges that most of us take for granted. The company’s mission is to make healthcare more accessible to…